Top Story

Handcuffs Gavel Social
Kickback
Texas lab owner pleads guilty in $1.7M Medicare fraud
A Plano, TX, lab owner has pleaded guilty to orchestrating a scheme to obtain $1.7 million from Medicare fraudulently, announced the office of the U.S. Attorney for the Northern District of Texas in a statement.
Featured
Cardiac Heart Eeg Social
Heart Disease
High-sensitivity assay improves diagnosis for patients with heart muscle injury in U.K. study
Artificial Intelligence Brain Close Social
Collaboration
King's College London, bit.bio collaboration launched to build multicell brain models
Latest News
Doctor Lab Test Bipoc Social
Imaware acquires Binx Health’s consumer-testing business
December 6, 2023
Cancer Therapy Targeted Social
Guardant Health, Cancer Research UK partner on data and research
December 5, 2023
Lawsuit Social
Court issues injunction against Invitae, ArcherDx in Natera patent infringement suit
December 4, 2023
Science Genome Sequence Dna Map Social
UK Biobank shares 500K WGS linked to 15 years of health data
December 4, 2023
Doctor Lab Test Bipoc Social
Mergers & Acquisitions
Imaware acquires Binx Health’s consumer-testing business
Collaboration
Guardant Health, Cancer Research UK partner on data and research
Lawsuit
Court issues injunction against Invitae, ArcherDx in Natera patent infringement suit
Trends and Finance
Personalis to cut workforce, forms new collaboration with Tempus
Science Genome Sequence Dna Map Social
Sequencing
UK Biobank shares 500K WGS linked to 15 years of health data
Antibiotic Resistance
U.K. researchers use deep learning to develop rapid antimicrobial resistance test
Artificial Intelligence
AI model could prevent unnecessary treatment for breast cancer patients, says study
FDA Clearance
KSQ Therapeutics receives FDA clearance for trial of CRISPR-Cas9 engineered tumor therapy
Lawsuit Social
Lawsuit
Court issues injunction against Invitae, ArcherDx in Natera patent infringement suit
Antibiotic Resistance
U.K. researchers use deep learning to develop rapid antimicrobial resistance test
Regulatory Guidance
FDA issues safety warning for risk of T-cell malignancies with CAR T-cell therapies
Artificial Intelligence
AI model could prevent unnecessary treatment for breast cancer patients, says study
More from LabPulse.com
Personalis to cut workforce, forms new collaboration with Tempus
In a strategy intended to cut costs, cancer genomics company Personalis has approved a layoff of up to 65 employees, approximately 20% of the Fremont, CA-based company’s workforce.
December 4, 2023
Layoff Woman Belongings Social
U.K. researchers use deep learning to develop rapid antimicrobial resistance test
Researchers are hailing progress toward more rapid detection of antimicrobial resistance (AMR), with a susceptibility test returning results in 30 minutes.
December 1, 2023
Antibiotic Resistant Bacteria Social
FDA issues safety warning for risk of T-cell malignancies with CAR T-cell therapies
The FDA issued a safety warning that patients who have received treatment with BCMA- or CD19-directed autologous CAR T-cell immunotherapies may be at higher risk of developing new T-cell malignancies, including CAR-positive lymphoma.
November 30, 2023
T Cell Social
AI model could prevent unnecessary treatment for breast cancer patients, says study
Breast cancer patients could be spared unnecessary chemotherapy with the use of a new artificial intelligence (AI) tool that helps predict survival risk, say researchers.
November 30, 2023
Breast Mammo Social
KSQ Therapeutics receives FDA clearance for trial of CRISPR-Cas9 engineered tumor therapy
Biotech firm KSQ Therapeutics has received clearance from the U.S. Food and Drug Administration (FDA) to proceed with a phase I and II trial of KSQ-001EX, KSQ’s CRISPR-Cas9 engineered tumor-infiltrating lymphocyte program.
November 29, 2023
Crispr Cas9 Gene Editing Social
Potential drug target to prevent small vessel disease identified in study
Scientists say lab-grown small blood vessels used in new disease models point to a theoretical potential treatment for a major cause of stroke and vascular dementia.
November 29, 2023
Brain Abstract Social
Candel Therapeutics to lay off 50% of workforce, refocus on advanced oncology immunotherapies
Candel Therapeutics, a biopharmaceutical company focused on developing cancer-fighting immunotherapies, will lay off 50% of its workforce.
November 28, 2023
Business Graph Money Stocks Social
Scipher Medicine, Quest Diagnostics collaborate on RA diagnostics
Scipher Medicine and Quest Diagnostics have announced a multiyear collaboration to expand access to diagnostic services for patients with rheumatoid arthritis (RA).
November 28, 2023
Blood Test Samples Lab Social
Nanopore sequencing slashes tumor analysis times and costs
Nanopore sequencing makes the analysis of copy number variations (CNVs) faster, cheaper, and simpler, according to a preprint paper from researchers at Dartmouth-Hitchcock Medical Center.
November 28, 2023
Dna Sequence Social
AI-powered blood test supports risk stratification of heart disease patients
A blood test powered by artificial intelligence (AI) has shown promise in the assessment of patients with total blockage of a heart artery.
November 27, 2023
Heart Pulmonary Trunk Social
Nasdaq issues delisting notice to T2 Biosystems
T2 Biosystems has received a delisting notice from Nasdaq after failing to satisfy the minimum $35 million market value of listed securities threshold required to remain listed.
November 27, 2023
Stock Exchange Social
Siemens Healthineers contracts with NIAID to develop NGS-based sepsis test
Siemens Healthineers has secured a three-year, $5.5 million contract with the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. National Institutes of Health, to develop a test to improve sepsis treatment.
November 22, 2023
Sepsis Bacteria Social